dimethyl sulfoxide has been researched along with Complex Regional Pain Syndromes in 2 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Complex Regional Pain Syndromes: Conditions characterized by pain involving an extremity or other body region, HYPERESTHESIA, and localized autonomic dysfunction following injury to soft tissue or nerve. The pain is usually associated with ERYTHEMA; SKIN TEMPERATURE changes, abnormal sudomotor activity (i.e., changes in sweating due to altered sympathetic innervation) or edema. The degree of pain and other manifestations is out of proportion to that expected from the inciting event. Two subtypes of this condition have been described: type I; (REFLEX SYMPATHETIC DYSTROPHY) and type II; (CAUSALGIA). (From Pain 1995 Oct;63(1):127-33)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Evidence suggests that complex regional pain syndrome (CRPS) is a manifestation of microvascular dysfunction." | 5.43 | A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients. ( Russo, MA; Santarelli, DM, 2016) |
| "The development and treatment ofthe complex regional pain syndrome type I (CRPS-I) are a subject of much discussion." | 2.44 | [Clinical practice guideline 'Complex regional pain syndrome type I']. ( Dijkstra, PU; Geertzen, JH; Perez, RS; Rosenbrand, CJ; Thomassen-Hilgersom, IL; Zollinger, PE; Zuurmond, WW, 2007) |
| "Evidence suggests that complex regional pain syndrome (CRPS) is a manifestation of microvascular dysfunction." | 1.43 | A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients. ( Russo, MA; Santarelli, DM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Russo, MA | 1 |
| Santarelli, DM | 1 |
| Perez, RS | 1 |
| Zollinger, PE | 1 |
| Dijkstra, PU | 1 |
| Thomassen-Hilgersom, IL | 1 |
| Zuurmond, WW | 1 |
| Rosenbrand, CJ | 1 |
| Geertzen, JH | 1 |
1 review available for dimethyl sulfoxide and Complex Regional Pain Syndromes
| Article | Year |
|---|---|
[Clinical practice guideline 'Complex regional pain syndrome type I'].
Topics: Acetylcysteine; Central Nervous System Diseases; Complex Regional Pain Syndromes; Dimethyl Sulfoxide | 2007 |
1 other study available for dimethyl sulfoxide and Complex Regional Pain Syndromes
| Article | Year |
|---|---|
A Novel Compound Analgesic Cream (Ketamine, Pentoxifylline, Clonidine, DMSO) for Complex Regional Pain Syndrome Patients.
Topics: Adrenergic alpha-Agonists; Adult; Analgesics; Anesthetics, Dissociative; Anti-Infective Agents, Loca | 2016 |